mitozolomide has been researched along with Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casali, A; Kok, T; Lucas, P; Rouëssé, J; Santoro, A; Seynaeve, C; Somers, R; Thomas, D; Verweij, J | 1 |
| Aamdal, S; Boyd, MR; Fodstad, O; Pihl, A | 1 |
1 trial(s) available for mitozolomide and Sarcoma
| Article | Year |
|---|---|
Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group.
Topics: Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Nitrogen Mustard Compounds; Sarcoma; Soft Tissue Neoplasms; Thrombocytopenia | 1992 |
1 other study(ies) available for mitozolomide and Sarcoma
| Article | Year |
|---|---|
Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Neoplasm Transplantation; Nitrogen Mustard Compounds; Sarcoma; Transplantation, Heterologous; Tumor Stem Cell Assay | 1985 |